Allison K, Patel D, Alabi O. Epidemiology of glaucoma: the past, present, and predictions for the future. Cureus. 2020;12:e11686.
Gedde SJ, Vinod K, Wright MM, Muir KW, Lind JT, Chen PP, et al. Primary open-angle glaucoma preferred practice pattern. Ophthalmology. 2021;128:P71–P150.
Balas M, Mathew DJ. Minimally invasive glaucoma surgery: a review of the literature. Vision. 2023;7:54.
Article PubMed PubMed Central Google Scholar
Micheletti JM, Brink M, Brubaker JW, Ristvedt D, Sarkisian SR. Standalone interventional glaucoma: evolution from the combination-cataract paradigm. J Cataract Refract Surg. 2024;50:1284–90.
Article PubMed PubMed Central Google Scholar
Funke CM, Ristvedt D, Yadgarov A, Micheletti JM. Interventional glaucoma consensus treatment protocol. Expert Rev. Ophthalmol. 2025;20:79–87.
Newman-Casey PA, Niziol LM, Gillespie BW, Janz NK, Lichter PR, Musch DC. The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study. Ophthalmology. 2020;127:477–83.
Article PubMed PubMed Central Google Scholar
Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627–35.
Skalicky SE, Goldberg I, McCluskey P. Ocular surface disease and quality of life in patients with glaucoma. Am J Ophthalmol. 2012;153:1–9.e2.
Lee S, Park DY, Huh MG, Cha SC. Influence of preoperative glaucoma medication on long-term outcomes of trabeculectomy. Sci Rep. 2024;14:28341.
Article CAS PubMed PubMed Central Google Scholar
Samuelson TW, Singh IP, Williamson BK, Falvey H, Lee WC, Odom D, et al. Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject® pivotal trial. Am J Ophthalmol. 2021;229:220–9.
Goel M, Picciani RG, Lee RK, Bhattacharya SK. Aqueous humor dynamics: a review. Open Ophthalmol J. 2010;4:52–59.
Article CAS PubMed PubMed Central Google Scholar
Craven ER, Katz LJ, Wells JM, Giamporcaro JE. Cataract surgery with trabecular micro-bypass stent implantation in patients with mild-to-moderate open-angle glaucoma and cataract: two-year follow-up. J Cataract Refract Surg. 2012;38:1339–45.
Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE. Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology. 2011;118:459–67.
Buffet J, Brasnu E, Baudouin C, Labbé A. Efficacy of 2 trabecular micro-bypass stents during phacoemulsification for mild to advanced primary open-angle glaucoma controlled with topical hypotensive medications. J Glaucoma. 2017;26:1149–54.
Ferguson TJ, Swan R, Ibach M, Schweitzer J, Sudhagoni R, Berdahl JP. Trabecular microbypass stent implantation with cataract extraction in pseudoexfoliation glaucoma. J Cataract Refract Surg. 2017;43:622–6.
Arriola-Villalobos P, Martinez-de-la-Casa JM, Diaz-Valle D, Morales-Fernandez L, Fernandez-Perez C, Garcia-Feijoo J. Glaukos iStent inject® trabecular micro-bypass implantation associated with cataract surgery in patients with coexisting cataract and open-angle glaucoma or ocular hypertension: a long-term study. J Ophthalmol. 2016;2016:1–7.
Hengerer FH, Auffarth GU, Riffel C, Conrad-Hengerer I. Prospective, non-randomized, 36-month study of second-generation trabecular micro-bypass stents with phacoemulsification in eyes with various types of glaucoma. Ophthalmol Ther. 2018;7:405–15.
Article PubMed PubMed Central Google Scholar
Voskanyan L, García-Feijoó J, Belda JI, Fea A, Jünemann A, Baudouin C. Prospective, unmasked evaluation of the iStent® inject system for open-angle glaucoma: synergy trial. Adv Ther. 2014;31:189–201.
Article PubMed PubMed Central Google Scholar
Inatani M, Kohama I, Chu A. Two-year post-market surveillance of iStent inject® W combined with phacoemulsification in Japanese open-angle glaucoma eyes. Clin Ophthalmol. 2025;19:1863–76.
Article PubMed PubMed Central Google Scholar
Ahmed IIK, Fea A, Au L, Ang RE, Harasymowycz P, Jampel HD, et al. A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma. Ophthalmology. 2020;127:52–61.
Smit BA, Johnstone MA. Effects of viscoelastic injection into Schlemm’s canal in primate and human eyes. Ophthalmology. 2002;109:786–92.
Patel S, Reiss G. Long-term clinical and safety outcomes of canaloplasty performed across all grades of glaucoma severity. J Ophthalmol. 2023;2023:1–8. https://onlinelibrary.wiley.com/doi/10.1155/2023/5625990.
Gillmann K, Aref A, Niegowski LJ, Baumgartner J-M. Combined Ab interno viscocanaloplasty (ABiC) in open-angle glaucoma: 12-month outcomes. Int Ophthalmol. 2021;41:3295–301.
Khaimi MA, Harvey BJ, Hsueh J, Leal C, Baykal A. Canaloplasty via an ab-interno surgical technique in patients with primary angle closure glaucoma. Int Ophthalmol. 2024;44:401.
Article PubMed PubMed Central Google Scholar
Gallardo MJ. 36-month effectiveness of ab-interno canaloplasty standalone versus combined with cataract surgery for the treatment of open-angle glaucoma. Ophthalmol Glaucoma. 2022;5:476–82.
Khaimi MA. Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery. Ther Adv Ophthalmol. 2021;13:251584142110457.
Khaimi MA, Koerber N, Ondrejka S, Gallardo MJ. Consistency in standalone canaloplasty outcomes using the iTrack microcatheter. Clin Ophthalmol. 2024;18:173–83.
Article PubMed PubMed Central Google Scholar
Koerber N, Ondrejka S. 6-year efficacy and safety of iTrack ab-interno canaloplasty as a stand-alone procedure and combined with cataract surgery in primary open angle and pseudoexfoliative glaucoma. J Glaucoma. 2024;33:176–82.
Gillmann K, Mansouri K. Minimally invasive glaucoma surgery: where is the evidence? Asia Pac J Ophthalmol. 2020;9:203–14.
Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St. Louis: The CV Mosby Co; 1993.
Glaukos Corporation. iStent inject® W. Available at: https://www.glaukos.com/glaucoma/products/istent-inject-w/ [Accessed February 19, 2025].
Shaarawy TM, Sherwood MB, Grehn F, editors. Guidelines on Design and Reporting of Surgical Trials - World Glaucoma Association. Amsterdam: Kugler Publications; 2009.
Gedde SJ, Vinod K, Bowden EC, Kolomeyer NN, Chopra V, Challa P, et al. Special commentary: reporting clinical endpoints in studies of minimally invasive glaucoma surgery. Ophthalmology. 2025;132:141–53.
European Glaucoma Society. European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021;105:1–169.
Ying G-S, Maguire MG, Glynn R, Rosner B. Tutorial on biostatistics: statistical analysis for correlated binary eye data. Ophthalmic Epidemiol. 2018;25:1–12.
Weinreb RN, World Glaucoma Association. Progression of glaucoma: the 8th consensus report of the World Glaucoma Association, Weinreb RN (ed). Paris: Kugler Publications; 2011.
Tan SZ, Au L. Manchester iStent study: 3-year results and cost analysis. Eye. 2016;30:1365–70.
Article CAS PubMed PubMed Central Google Scholar
Clement CI, Howes F, Ioannidis AS, Shiu M, Manning D. One-year outcomes following implantation of second-generation trabecular micro-bypass stents in conjunction with cataract surgery for various types of glaucoma or ocular hypertension: multicenter, multi-surgeon study. Clin Ophthalmol. 2019;13:491–9.
Article CAS PubMed PubMed Central Google Scholar
Gołaszewska K, Obuchowska I, Konopińska J. First-generation iStent bypass implantation versus ab externo canaloplasty combined with phacoemulsification in patients with primary open angle glaucoma—12-month follow-up. J Clin Med. 2023;12:5711.
Comments (0)